Table 3.
Provider participant demographics
| Characteristics | Overall (N = 215) | Kenya (n = 105) | Zambia (n = 110) | P value* |
|---|---|---|---|---|
| Sex, n (%) | ||||
| Male | 112 (52) | 51 (49) | 61 (55) | 0.31 |
| Female | 103 (48) | 54 (51) | 49 (45) | |
| Years in practice, n (%) | ||||
| 0–5 | 100 (47) | 33 (31) | 67 (61) | < 0.001 |
| 6–10 | 62 (29) | 38 (36) | 24 (22) | |
| 11–15 | 25 (12) | 18 (17) | 7 (6) | |
| 16–20 | 13 (6) | 9 (9) | 4 (4) | |
| 21 or more | 15 (7) | 7 (7) | 8 (7) | |
| Professional background, n (%) | ||||
| Medical doctor or medical officer | 14 (7) | 4 (4) | 10 (9) | 0.043 |
| Nurse | 132 (61) | 60 (57) | 72 (65) | |
| Clinical officer or medical licentiate | 46 (21) | 28 (27) | 18 (16) | |
| Pharmacist/other | 19 (9)/4 (2) | 9 (9)/4 (4) | 10 (9)/0 (0) | |
| Practice description, n (%) | ||||
| Private office or clinic | 18 (8) | 18 (17) | 0 (0) | < 0.001 |
| Community hospital/clinic | 41 (19) | 16 (15) | 25 (23) | |
| Local or regional public health clinic | 24 (11) | 3 (3) | 21 (19) | |
| Health department or ministry of health | 132 (61) | 68 (65) | 64 (58) | |
| Number of patients they prescribed malaria chemoprevention in the past year, n (%) | ||||
| < 10 | 31 (16) | 2 (2) | 29 (30) | < 0.001 |
| 11–100 | 55 (29) | 23 (25) | 32 (33) | |
| 101–500 | 35 (18) | 17 (18) | 18 (18) | |
| > 500 | 69 (36) | 50 (54) | 19 (19) | |
*
Comparisons between Zambia and Kenya respondents, P values from Fisher’s exact tests.